TheEdgeResearch
Home / Stocks / UNVO.TA

Univo Pharmaceuticals Ltd (UNVO.TA)

TLV Healthcare Biotechnology
$9.40 ▲ +1.08%
Market Cap
$287.3M
Sector
Healthcare
Industry
Biotechnology
Beta
0.77
52-Wk Range
0.09-10.0
CEO
Golan Bitton
Country
IL
Currency
ILA

Univo Pharmaceuticals Ltd operates in the Biotechnology industry of the Healthcare sector, headquartered in Ashkelon, IL. The stock last traded at $9.40, up 1.08% on the session, giving a market capitalisation of $287.3M. Its beta of 0.77 implies it has historically moved less than the broad market.

Company profile
Exchange
Tel Aviv Stock Exchange
Employees
76
IPO date
2010-11-09
Headquarters
Ashkelon, IL
About Univo Pharmaceuticals Ltd

Based in Ashkelon, Israel, Univo Pharmaceuticals Ltd, founded in 1993, focuses on the creation, production, and distribution of medical cannabis items. The company adopted its present name, Univo Pharmaceuticals Ltd, in September 2018, having previously been known as Di-Pharm Ltd.

Comparable companies

Univo Pharmaceuticals Ltd is most often compared with the following Healthcare names:

AMDA.TACNZN.TACSURE.TAEFNC.TAENDY.TAENVM.TAHUMX.TANXGN.TANXTG.TASLGN.TA
More research on UNVO.TA
UNVO.TA technical analysis UNVO.TA TheEdge Score Compare against peers
Open full interactive analysis & DCF →